Biodexa Pharmaceuticals Plc (BDRX)
0.392
-0.06
(-14.05%)
USD |
NASDAQ |
Oct 19, 15:33
Biodexa Pharmaceuticals Cash from Operations (Annual) : -7.268M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -7.268M |
| December 31, 2024 | -15.44M |
| December 31, 2023 | -8.410M |
| December 31, 2022 | -8.668M |
| December 31, 2021 | -8.284M |
| December 31, 2020 | -11.97M |
| December 31, 2019 | -8.306M |
| Date | Value |
|---|---|
| December 31, 2018 | -18.71M |
| December 31, 2017 | -16.80M |
| December 31, 2016 | -17.49M |
| December 31, 2015 | -18.87M |
| December 31, 2014 | -9.047M |
| December 31, 2013 | -2.738M |
| December 31, 2012 | -2.726M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| NuCana Plc | -9.377M |
| Mereo BioPharma Group Plc | -31.04M |
| BioNTech SE | 514.63M |
| Silence Therapeutics Plc | -62.27M |
| Autolus Therapeutics Plc | -284.23M |